drugset / Trial / NCT01591980

Effects of Perioperative Pregabalin for Post-Craniotomy Pain

NCT01591980

Phase 4 Withdrawn Unity Health Toronto
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Objective: To compare the incidence of chronic pain at 3 months among adults undergoing craniotomy between those received two different doses of pregabalin and those receiving placebo.

Timeline

Start
2013-08
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 100 mg
Subject Pregabalin Small molecule 150 mg